Care Pathways for Benchmarking on Fragile Hip Fractures Rapid Recovery

July 26, 2021 updated by: Dr. Kris Vanhaecht, European Pathway Association

The aim of this project is to build an international community of centers of excellence in the care for Fragile Hip Fracture Rapid Recovery patients. These centers of excellence will benchmark and share their expertise and experiences based on clinical and managerial data. In project is designed in five different phase:

Phase 1: literature review: identifying relevant key interventions and indicators Phase 2: expert panel: expert panel for teams, management and policy makers Phase 3: data collection: collection managerial data through retrospective patient record analysis on clinical indicators Phase 4: statistical data analysis: data input, validation and statistical analysis Phase 5: feedback and knowledge sharing: feedback report with anonymous benchmarking and knowledge sharing of the results.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

298

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Belgium
      • Leuven, Belgium
        • KU Leuven

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patient admitted with a proximal femur fracture

Description

Inclusion Criteria:

  • Trauma related non-elective admission for hip fracture;
  • Minimum age of 65 years;
  • The following hip fractures are included: Femoral neck, femoral head, trochanteric and subtrochanteric fractures;
  • Discharged or deceased before May 30th of 2019

Exclusion Criteria:

  • Hip fracture is not the main reason for admission to emergency room;
  • Additional ipsilateral fractures;
  • Hip fracture resulting from in-hospital fall that occurred in the hospital where the patient receives hip fracture care.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Performance on quality indicators at patient level (Quality of Care and patient satisfaction) for patients admitted with a fragile hip fracture.
Time Frame: through study completion, an average of 1 year
This study evaluates quality indicators at patient level as defined by the expert panel to determine appropriateness of fragile hip fracture indicators. The indicators will cover the pre-operative, peri-operative and post-operative care process. The data will be selected out of the patient record. Based on the expert panel quality of care is measured by time to surgery, information on pre-fall cognitive status, information on pre-fall mobility status, fasting time, administration of carbohydrate loading, administration of cortical steriods, use of tranexamic acid, urinary catheterization, administration of pain medication, time to post operative surgeon note for care team, time of drain duration, type of anesthesia, measurement of haemoglobin, mobilisation post-operative, following of pain protocol, plan for discharge, nutrition supplementation. he study is limited to the period in which the patients are hospitalized. No data is gathered before or after hospitalization.
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

European Pathway Association

Collaborators

KU Leuven

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2020

Primary Completion (Actual)

June 27, 2020

Study Completion (Actual)

December 31, 2020

Study Registration Dates

First Submitted

May 6, 2019

First Submitted That Met QC Criteria

May 6, 2019

First Posted (Actual)

May 7, 2019

Study Record Updates

Last Update Posted (Actual)

July 27, 2021

Last Update Submitted That Met QC Criteria

July 26, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CP4FHF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fractures

Clinical Trials on Usual care

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe